Get Healthy!

Popular Diabetes and Weight-loss Drug May Lower Alzheimer’s Risk

A new study finds type 2 diabetes patients taking semaglutide have much lower odds of developing Alzheimer’s disease, regardless of weight, gender or age.

HealthDay
Health News is provided as a service to Meadowmont Pharmacy site users by HealthDay. Meadowmont Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2025 HealthDay All Rights Reserved.